ONLINE Navigating NIH’s Pre- and Post-Doctoral Diversity Funding Mechanisms: Strategies, Tips, and Tricks

DOWNLOAD SLIDES: Click here

Download a Handout that lists NIH Diversity Funding Mechanisms (click)

This workshop will address both practical and conceptual aspects of the National Institute of Health’s Diversity funding mechanisms at both the pre- and post-doctoral training levels as well as early career level. Participants will learn about the various funding mechanisms aimed at increasing diversity, develop strategies and grant writing skills for preparing more effective proposals. Dynamic presenters including current and former NIH diversity funding recipients who will share insights about the application process, grant writing and review the process for diversity funding proposals. There will be a specific focus on the Pre- and Post-Doctoral Research Supplements to Promote Diversity in Health-Related Research and specific K Awards to promote research independence.

NIH NHLBI’s Program Officers, Drs. Jane Scott and Josephine Boyington will also be available to provide guidance and advice.

NIH MOSAIC (Maximizing Opportunities for Scientific and Academy Independent Careers) and NHLBI’s PRIDE (Program to Increase Diversity Among Individuals Engaged in Health-Related Research) programs will be highlighted. 

NOTE: Most NIH diversity funding requires the individual to be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551), or other legal verification of such status, by the time of award.

Resources:

NIH Diversity Supplements: https://grantwriting.stanford.edu/diversity-supplements/

NIH Diversity K Awards: https://grantwriting.stanford.edu/diversity-k-awards/

About the Speaker:

Hoda Abdel Magid, PhD, MHS, is a Post-Doctoral Fellow in the Department of Epidemiology and Population Health at Stanford University and the Palo Alto VA. Dr. Abdel Magid received her Doctorate in Epidemiology from the University of California, Berkeley in 2018 with a focus in Social Epidemiology and Masters of Health Science in Environmental Epidemiology from The Johns Hopkins Bloomberg School of Public Health in 2015.  Her graduate career research promoted the understanding of new and emerging tobacco products use among adolescents and young adults.  Dr. Abdel Magid’s current research builds upon her previous training to further understand high risk chronic disease behaviors to gain insights pertaining to health disparities among safety net populations.

About the Panelists:

Omokolade (Kolode) Adebowale: I completed my undergraduate degree in chemical engineering at Illinois Institute of Technology. I am a rising 6th year graduate student in chemical engineering. My current research aims to understand how mechanical properties of hydrogels, specifically viscoelasticity, impacts cancer cell migration, a key aspect of metastasis. Pre-covid (and hopefully post-covid), I enjoy the outdoors and exploring San Francisco.

Andrea d’Aquino: Andrea is currently a postdoctoral scholar in the Appel lab in the Materials Science and Engineering Department, and her research interests lie at the intersection of chemistry, biology and engineering. She is interested in developing novel biomaterials for therapeutic applications and motivated to address the growing need for effective drug delivery technologies.

Stefan Veizades: Stefan Veizades is an undergraduate fellow in the Department of Cardiovascular Medicine at Stanford in the lab of Patricia Nguyen and a third year undergraduate at the University of Edinburgh, studying Medical Sciences. His research focuses on the pathogenesis of atherosclerosis, specifically the role T cells play.

Nazish Sayed: Dr. Sayed earned his MD from University of Mumbai, India, trained in Int Med and obtained a PhD in Physiology and Pharmacology at Rutgers New Jersey Medical School. He continued his postdoc at Stanford in cardiovascular and regenerative medicine. As an Instructor, Dr. Sayed has established an endothelial regeneration program and is the main lead on projects related to characterization of human iPSC-derived endothelial cells (iPSC-ECs) in the Stanford Cardiovascular Institute. He has been funded by the American Heart Association and NIH, including the NHLBI K01 Career Development Award